Teva Pharmaceutical Industries Shares Rise After JPMorgan Upgrades Rating

MT Newswires Live
16小時前

Teva Pharmaceutical Industries (TEVA) shares were up 5.2% in recent trading on Monday after JPMorgan Upgrades rating to overweight from neutral.

The firm raised its price target on the company's stock to $23 from $21.

Trading volume stood at about 12.7 million shares against a daily average of 12.6 million.

Price: 17.83, Change: +0.90, Percent Change: +5.32

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10